[Treatment of systemic necrotizing vasculitis].
Guillevin
L
L
Service de médecine interne, hôpital Avicenne, Université Paris Nord, 125, rue de Stalingrad, 9300 Bobigny, France.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009336:Necrosis; D018579:Patient Selection; D010951:Plasma Exchange; D010488:Polyarteritis Nodosa / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D013256:Steroids; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D013256:Steroids
Traitement des vascularites nécrosantes systémiques.